Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 6Venous Thrombosis 5Neoplasms 5Pulmonary Embolism 4Neoplasm Metastasis 2Intracranial Thrombosis 2Thrombosis 1Thromboprophylaxis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Mesenteric Ischemia 1Lymphoma 1Hematologic Neoplasms 1

Interventions

apixaban 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Thromboprophylaxis × apixaban × Clear all
NCT07160686 2025-09-08

THROMBO-STOP

University of Birmingham

Phase 3 Not yet recruiting
1,456 enrolled

Thromboprophylaxis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡